ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL

被引：1
|
作者：
Brennan, A. [1 ]
Gillett, M. [1 ]
Duenas, A. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66666-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS ADD-ON TO METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN GREECE
    Tzanetakos, C.
    Tentolouris, N.
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2015, 18 (07) : A606 - A607
  • [12] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Odawara, Masato
    Hamada, Izumi
    Suzuki, Manabu
    DIABETES THERAPY, 2014, 5 (01) : 169 - 181
  • [13] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Masato Odawara
    Izumi Hamada
    Manabu Suzuki
    Diabetes Therapy, 2014, 5 : 169 - 181
  • [14] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Charalampos Tzanetakos
    Nicholas Tentolouris
    Georgia Kourlaba
    Nikos Maniadakis
    Clinical Drug Investigation, 2016, 36 : 649 - 659
  • [15] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Tzanetakos, Charalampos
    Tentolouris, Nicholas
    Kourlaba, Georgia
    Maniadakis, Nikos
    CLINICAL DRUG INVESTIGATION, 2016, 36 (08) : 649 - 659
  • [16] The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
    Gordon, Jason
    McEwan, Phil
    Hurst, Michael
    Puelles, Jorge
    DIABETES THERAPY, 2016, 7 (04) : 825 - 845
  • [17] The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
    Jason Gordon
    Phil McEwan
    Michael Hurst
    Jorge Puelles
    Diabetes Therapy, 2016, 7 : 825 - 845
  • [18] ECONOMIC EVALUATION OF VILDAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN DIABETES MELLITUS TREATMENT IN CHINA
    Chen, W.
    Zhu, J.
    VALUE IN HEALTH, 2012, 15 (07) : A664 - A664
  • [19] Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes
    Al-Azzam, Sayer I.
    AlOmari, Mousa
    Khader, Yousef S.
    AlMahasneh, Fatimah A.
    Muflih, Suhaib M.
    Altawalbeh, Shoroq
    ENDOCRINE RESEARCH, 2012, 37 (01) : 7 - 11
  • [20] COMPARISON OF VILDAGLIPTIN AS AN ADD-ON THERAPY AND SULFONYLUREA DOSE-INCREASING THERAPY IN PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES USING METFORMIN AND SULFONYLUREA
    Hong, A. R.
    Lee, J.
    Ku, E. J.
    Hwangbo, Y.
    Kim, K. M.
    Moon, J. H.
    Choi, S. H.
    Jang, H. C.
    Lim, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S141 - S141
12345